{"id":"W2167828574","doi":"10.1177/2040622313492810","title":"Teriflunomide in relapsing multiple sclerosis: therapeutic utility","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Discontinuation; Adverse effect; Glatiramer acetate; Dimethyl fumarate; Oncology; Intensive care medicine; Internal medicine; Fingolimod; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001089255,0.0002851575,0.0006846507,0.000882706,0.000174517,0.0006074741,0.0002797137,0.0005918398,0.001912931],"category_scores_gemma":[0.0007638927,0.00007554046,0.0002962623,0.0007701827,0.0003671462,0.0004730956,0.0002174268,0.0007900523,0.0004113602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000272075,"about_ca_system_score_gemma":0.0003205775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004320315,"about_ca_topic_score_gemma":0.001254358,"domain_scores_codex":[0.9998161,0.00008749714,0.00002460208,0.00001797416,0.00003647239,0.00001736298],"domain_scores_gemma":[0.9994736,0.0002703795,0.0001328565,0.00002128485,0.00005026032,0.00005164532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002792353,0.0006928849,0.002732868,0.003932602,0.0002078344,0.001298399,0.0001186265,0.0003802006,0.01835758,0.001611516,0.00288524,0.9649899],"study_design_scores_gemma":[0.009695067,0.05538729,0.08811349,0.01061767,0.003160398,0.02365395,0.0008213745,0.002141052,0.07696274,0.008999192,0.7203053,0.00014251],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03816681,0.9515715,0.0004308141,0.001594569,0.0001074391,0.00005086933,0.00008875136,0.00002393362,0.007965365],"genre_scores_gemma":[0.3153865,0.6802259,0.001230757,0.0009358543,0.0005896536,0.00004976011,0.0001241188,0.000006154644,0.001451244],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001912931,"threshold_uncertainty_score":0.006399333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07470561988529514,"score_gpt":0.346559401018863,"score_spread":0.2718537811335678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}